Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer
Authors
Keywords
Oxaliplatin, Minnelide, Triptolide, NER, DNA damage pancreatic cancer
Journal
JOURNAL OF GASTROINTESTINAL SURGERY
Volume 20, Issue 1, Pages 13-24
Publisher
Springer Nature
Online
2015-10-27
DOI
10.1007/s11605-015-3000-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synergistic Antitumor Effect of Triptolide and Cisplatin in Cisplatin Resistant Human Bladder Cancer Cells
- (2015) Jin-Nyoung Ho et al. JOURNAL OF UROLOGY
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Predictive value of APE1, BRCA1, ERCC1 and TUBB3 expression in patients with advanced non-small cell lung cancer (NSCLC) receiving first-line platinum–paclitaxel chemotherapy
- (2014) Zheng Li et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Frontline treatment with gemcitabine, oxaliplatin and erlotinib for the treatment of advanced or metastatic pancreatic cancer: a multicenter phase II study of the Hellenic Oncology Research Group (HORG)
- (2014) O. Katopodis et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Triptolide sensitizes pancreatic cancer cells to TRAIL-induced activation of the Death Receptor pathway
- (2014) Zhiyu Chen et al. CANCER LETTERS
- ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum Resistance
- (2014) J. D. Kuhlmann et al. CLINICAL CHEMISTRY
- Triptolide Synergistically Enhances Antitumor Activity of Oxaliplatin in Colon Carcinoma In Vitro and In Vivo
- (2014) Yisheng Liu et al. DNA AND CELL BIOLOGY
- Sorafenib and triptolide as combination therapy for hepatocellular carcinoma
- (2014) Osama A. Alsaied et al. SURGERY
- The prognostic value of ERCC1 expression in gastric cancer patients treated with platinum-based chemotherapy: a meta-analysis
- (2014) Kong-Kong Wei et al. TUMOR BIOLOGY
- ERCC1 expression levels predict the outcome of platinum-based chemotherapies in advanced bladder cancer
- (2013) Shan Li et al. ANTI-CANCER DRUGS
- Recent progress in pancreatic cancer
- (2013) Christopher L. Wolfgang et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo
- (2012) Chia-Jung Li et al. CANCER LETTERS
- Systemic Therapies for Pancreatic Cancer - The Role of Pharmacogenetics
- (2012) Ross A. Soo et al. CURRENT DRUG TARGETS
- DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy
- (2012) E. M. McNeil et al. NUCLEIC ACIDS RESEARCH
- Inhibition of Gli1 results in altered c-Jun activation, inhibition of cisplatin-induced upregulation of ERCC1, XPD and XRCC1 and inhibition of platinum–DNA adduct repair
- (2012) K Kudo et al. ONCOGENE
- Triptolide Cooperates With Cisplatin to Induce Apoptosis in Gemcitabine-Resistant Pancreatic Cancer
- (2012) Wenbo Zhu et al. PANCREAS
- A Preclinical Evaluation of Minnelide as a Therapeutic Agent Against Pancreatic Cancer
- (2012) R. Chugh et al. Science Translational Medicine
- Use of the γ-H2AX assay to monitor DNA damage and repair in translational cancer research
- (2011) Alesia Ivashkevich et al. CANCER LETTERS
- Oxaliplatin: a review in the era of molecularly targeted therapy
- (2011) T. Alcindor et al. Current Oncology
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gemcitabine and Oxaliplatin Combination Chemotherapy for Patients with Refractory Pancreatic Cancer
- (2011) Hiroyuki Isayama et al. ONCOLOGY
- Triptolide Induces Cell Death in Pancreatic Cancer Cells by Apoptotic and Autophagic Pathways
- (2010) Nameeta Mujumdar et al. GASTROENTEROLOGY
- Retracted: Restoring sensitivity to oxaliplatin by a novel approach in gemcitabine-resistant pancreatic cancer cellsin vitroandin vivo
- (2010) Sanjeev Banerjee et al. INTERNATIONAL JOURNAL OF CANCER
- γH2AX: a sensitive molecular marker of DNA damage and repair
- (2010) L-J Mah et al. LEUKEMIA
- TRAIL and Triptolide: An Effective Combination that Induces Apoptosis in Pancreatic Cancer Cells
- (2009) Daniel Borja-Cacho et al. JOURNAL OF GASTROINTESTINAL SURGERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now